The S&P 500 ended higher on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations ...

The S&P 500 rose on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations with ...

The most recent trading session ended with Eli Lilly (LLY) standing at $827.54, reflecting a +1.16% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 2.51%.

Tobacco giant Altria (NYSE: MO) provides a tremendously high dividend yield of 7%, which is well above the S&P 500 index average ... Meanwhile, pharma company Eli Lilly (NYSE: LLY) offers a ...

Wall Street stocks ended mixed on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations with Japan against concerns about the interest rate outlook.

Shares of Eli Lilly (LLY) jumped 16% Thursday morning to lead S&P 500 gainers after the pharmaceutical company released clinical trial results for its oral weight-loss drug that "demonstrated ...

US-Japan tariff talks on radar Alphabet falls after ruling Insurers slump after UnitedHealth results S&P 500 +0.13% ... lifted by Eli Lilly and Apple, as investors weighed progress in U.S ...

S&P 500 futures rose 0.3% ... and maintaining its full-year outlook despite tariff concerns. Daily Eli Lilly and Company Eli Lilly surged 11% following positive phase-three trial results for ...

Eli Lilly has been raising its dividend at a ... 476% in value while Altria has risen by around 52% (which lags the S&P 500's returns of more than 116%). A soaring stock will see its yield fall ...